The launch of self-administered pharmacy benefit biosimilars has added to the growing landscape of approved and upcoming products in the US. Industry players are using innovative strategies to improve patient access. Payers and providers are responding to these products by considering therapeutic areas, pipeline, regulatory environment, and utilizing real-world evidence. Join our expert panel, Tasmina Hydery, Lakesha Farmer, and Cate Lockhart, as they discuss these topics, including biosimilar management strategies and challenges with real-world data.

This session will review innovative care models through collaboration with Health System Integrated Specialty Pharmacies and Medically Integrated Physician Practices utilizing relationship between managed care and specialty service organizations. The presentation will cover strategies to disintermediate existing payment and care barriers through coordinating credentialing, network terms and member communication. Speaker(s) will review compelling cost of care and member satisfaction results in an existing medically integrated dispensing program including pathways to successful implementation.